Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?
Sarepta Therapeutics Ownership Summary
Sarepta Therapeutics is owned by 91.29% institutional investors, 4.37% insiders, and 4.34% retail investors. Blackrock is the largest institutional shareholder, holding 10.98% of SRPT shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.14% of its assets in Sarepta Therapeutics shares.
SRPT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Sarepta Therapeutics | 91.29% | 4.37% | 4.34% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 10.32M | 10.98% | $1.63B |
Vanguard group | 9.04M | 9.61% | $1.43B |
Capital investors | 4.32M | 4.60% | $682.69M |
State street | 4.14M | 4.41% | $654.40M |
Janus henderson group | 3.82M | 4.06% | $602.74M |
Avoro capital advisors | 3.00M | 3.19% | $474.00M |
Morgan stanley | 2.62M | 2.79% | $414.49M |
Bank of new york mellon | 2.13M | 2.27% | $336.64M |
Wellington management group llp | 2.06M | 2.19% | $325.72M |
T. rowe price investment management | 1.96M | 2.08% | $309.46M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Casdin capital | 1.07M | 12.95% | $169.61M |
Ally bridge group (ny) | 73.50K | 6.92% | $11.61M |
Avoro capital advisors | 3.00M | 6.31% | $474.00M |
Finepoint capital lp | 132.84K | 5.96% | $20.99M |
Boxer capital | 650.00K | 5.41% | $102.70M |
Altium capital management lp | 81.90K | 5.28% | $12.94M |
Palo alto investors lp | 201.68K | 3.69% | $31.87M |
Evolutionary tree capital management | 20.96K | 3.41% | $3.31M |
Ikarian capital | 1.00K | 2.75% | $15.80M |
Ghost tree capital | 55.00K | 2.72% | $8.69M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 10.32M | 0.04% | 4.36M |
State street | 4.14M | 0.03% | 2.02M |
Morgan stanley | 2.62M | 0.03% | 1.73M |
Norges bank | 924.43K | 0.02% | 924.43K |
Jane street group | 869.13K | 0.03% | 591.02K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -1.41M |
Avoro capital advisors | 3.00M | 6.31% | -1.34M |
Wellington management group llp | 2.06M | 0.06% | -1.18M |
Janus henderson group | 3.82M | 0.32% | -1.08M |
Paradigm biocapital advisors lp | - | - | -947.57K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 924.43K | 0.02% | 924.43K | $146.06M |
Farallon capital management | 133.30K | 0.10% | 133.30K | $21.06M |
Balyasny asset management | 125.00K | 0.03% | 125.00K | $19.75M |
Corebridge financial | 120.64K | 0.10% | 120.64K | $19.06M |
Retirement systems of alabama | 116.67K | 0.07% | 116.67K | $18.43M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Harbor investment advisory | -1.00 |
Financial synergies wealth advisors | -3.00 |
Geneos wealth management | -4.00 |
Financial management professionals | -4.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 498 | -6.57% | 87,082,917 | -1.33% | 91 | 1.04% | 226 | -23.65% | 157 | 18.05% |
Jun 30, 2024 | 528 | 18.39% | 88,255,346 | 8.04% | 93 | 1.24% | 293 | 35.02% | 132 | 4.76% |
Mar 31, 2024 | 446 | 1.59% | 81,685,557 | 0.50% | 86 | 1.12% | 217 | 7.43% | 126 | -11.89% |
Dec 31, 2023 | 439 | -1.79% | 81,281,399 | -0.52% | 87 | 1.04% | 202 | -1.94% | 143 | 12.60% |
Sep 30, 2023 | 447 | 1.13% | 81,706,199 | 0.21% | 91 | 1.09% | 206 | -0.48% | 127 | -5.93% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Mid-Cap ETF | 3.00M | 3.14% | 1.63K |
Vanguard Total Stock Mkt Idx Inv | 2.84M | 2.98% | -11.17K |
Vanguard Small Cap Index | 2.27M | 2.38% | 4.45K |
VA CollegeAmerica Amcap 529A | 2.10M | 2.20% | 902.69K |
Capital Group AMCAP Composite | 2.10M | 2.20% | 902.69K |
Vanguard Health Care Inv | 1.66M | 1.74% | 390.96K |
Capital Group Growth Fnd of Amer Comp | 1.65M | 1.73% | 194.73K |
American Funds Growth Fund of Amer A | 1.65M | 1.73% | 194.73K |
SPDR® S&P Biotech ETF | 1.50M | 1.57% | 16.57K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.42M | 1.49% | -7.05K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 12, 2024 | Wigzell Hans Lennart Rudolf | - | Sell | $1.31M |
Dec 05, 2024 | Boor Kathryn Jean | - | Sell | $205.40K |
Aug 30, 2024 | Estepan Ian Michael | Chief Financial Officer | Sell | $822.10K |
Aug 16, 2024 | Chambers Michael Andrew | - | Buy | $2.45M |
Aug 16, 2024 | Chambers Michael Andrew | - | Buy | $1.74M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q3 | 3 | 1 |
2024 Q2 | - | 14 |
2024 Q1 | - | 9 |
2023 Q4 | 6 | - |
SRPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools